April 26, 2023
Teladoc Health Reports First Quarter 2023 Results
First quarter 2023 revenue grows 11% year-over-year to $629.2 million First quarter 2023 net loss of $69.2 million, or $0.42 per share First quarter adjusted EBITDA totaled $52.8 million PURCHASE, NY, April 26, 2023 (GLOBE NEWSWIRE) - Teladoc Health, Inc. (NYSE: TDOC), the global leader in whole-person virtual care, today reported financial results for the first quarter ended March 31, 2023. “Teladoc Health delivered strong first quarter results across all key financial and operating metrics to start the year,” said Jason Gorevic, chief executive officer of Teladoc Health. “With a strong financial position, we are able to fund and invest in innovations and a world-class team of medical professionals as we support leading employers, health plans, hospital systems, and governments around the world. We have solid momentum heading into the rest of the year as the market embraces Teladoc Health’s unified whole person care experience.” ...
Read More
April 12, 2023
Teladoc Health to Announce First Quarter 2023 Financial Results
PURCHASE, NY, April 12, 2023 (GLOBE NEWSWIRE) - Teladoc Health , Inc. (NYSE: TDOC), the global leader in whole-person virtual care, announced that it will release first quarter 2023 results on Wednesday, April 26, 2023, after the market closes. In conjunction, the company will host a conference call to review results at 4:30 p.m. E.T. on the same day. Conference Call Details The conference call can be accessed by dialing 1-833-470-1428 for U.S. participants and using the access code # 517662. For international participants, please visit the following link for global dial-in numbers: https://www.netroadshow.com/events/global-numbers?confId=48865 . A live audio webcast will also be available online at https://ir.teladochealth.com/news-and-events/events-and-presentations/ .
A replay of the call will be available via webcast for on-demand listening shortly after the completion of the call, at the same web link, and will remain available for approximately 90 days. About Teladoc...
Read More